Lymphoma, particularly the large, B-cell subtype, is one of the most common malignancies in dogs. Canine lymphoma can be treated, but it is rarely cured. Novel therapeutic strategies are necessary to improve outcomes in dogs diagnosed with lymphoma. Recently, advances in the understanding of human lymphomas have focused on the area of epigenetics.
Research Update End-year 2 CHF 02502: Precision Medicine for Canine Lymphoma
This AKC-CHF sponsored award supported the successful development of a comprehensive canine tumor sequencing panel (“canine oncopanel”) using cutting-edge, next-generation sequencing technology.
Continue reading “Research Update End-year 2 CHF 02502: Precision Medicine for Canine Lymphoma”
CHF Grant 02317 Update End-Year 3: The Role of Complex Translocations Associated with TP53 Somatic Mutations for Aiding Prognosis of Canine Diffuse Large B-Cell Lymphoma
Update on treatment of B-cell lymphoma from Dr Breen.
Grant 02309-T Update End Year 3: Targeting the Cancer Epigenome: The Effect of Specific Histone Lysine Methyltransferase Inhibition in Canine B-Cell Lymphoma
Update on targeting epigenome for treatment of B-cell lymphoma from Dr McCleary-Wheeler.
Research Update Mid-Year-2 CHF-02502: Precision Medicine for Canine Lymphoma
Research update from Dr. Nicola Mason to profile lymphoma and enable targeted therapy.
Continue reading “Research Update Mid-Year-2 CHF-02502: Precision Medicine for Canine Lymphoma”
Research Final Update CHF-02318: Genetic and Environmental Risk for Lymphoma in Boxer Dogs
Final Research Update from Dr. Trepanier on genetic and environmental risks of lymphoma in Boxer dogs.
Research Update Mid-Year 3 CHF-02317: The Role of Complex Translocations Associated with TP53 Somatic Mutations for Aiding Prognosis of Canine Diffuse Large B-Cell Lymphoma
Research Update from Dr. Breen regarding aiding prognosis of Canine Diffuse Large B-Cell Lymphoma.
Research Update Mid-year 3 CHF 02309-T: Targeting the Cancer Epigenome: The Effect of Specific Histone Lysine Methyltransferase Inhibition in Canine B-Cell Lymphoma
Research Update from Dr. McCleary-Wheeler targeting epigenetics in Lymphoma.
Research Update End-Year-2 CHF 02309-T: Targeting the Cancer Epigenome: The Effect of Specific Histone Lysine Methyltransferase Inhibition in Canine B-Cell Lymphoma
Research Update from Dr. McCleary-Wheeler targeting epigenetics in Lymphoma.
Research Update End-Year 2 CHF-02317: The Role of Complex Translocations Associated with TP53 Somatic Mutations for Aiding Prognosis of Canine Diffuse Large B-Cell Lymphoma
Research Update from Dr. Breen regarding aiding prognosis of Canine Diffuse Large B-Cell Lymphoma.
